Correlation Between CureVac NV and Vir Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Vir Biotechnology, you can compare the effects of market volatilities on CureVac NV and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Vir Biotechnology.

Diversification Opportunities for CureVac NV and Vir Biotechnology

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between CureVac and Vir is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of CureVac NV i.e., CureVac NV and Vir Biotechnology go up and down completely randomly.

Pair Corralation between CureVac NV and Vir Biotechnology

Given the investment horizon of 90 days CureVac NV is expected to under-perform the Vir Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, CureVac NV is 1.06 times less risky than Vir Biotechnology. The stock trades about -0.06 of its potential returns per unit of risk. The Vir Biotechnology is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  1,063  in Vir Biotechnology on August 30, 2024 and sell it today you would lose (277.00) from holding Vir Biotechnology or give up 26.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CureVac NV  vs.  Vir Biotechnology

 Performance 
       Timeline  
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CureVac NV is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Vir Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vir Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Vir Biotechnology is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

CureVac NV and Vir Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CureVac NV and Vir Biotechnology

The main advantage of trading using opposite CureVac NV and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.
The idea behind CureVac NV and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets